FOXP3 and neoplasm: Has our understanding thus far of intra-tumoral Foxp3+ T cell-enrichment identified mechanisms through which their potential influence on the anti-tumor immune response can be modulated and used to improve current T cell-orientated treatments (Figure 2)?